These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 16847334)

  • 1. Functional interaction between peroxisome proliferator-activated receptor gamma and beta-catenin.
    Liu J; Wang H; Zuo Y; Farmer SR
    Mol Cell Biol; 2006 Aug; 26(15):5827-37. PubMed ID: 16847334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cladosporol A, a new peroxisome proliferator-activated receptor γ (PPARγ) ligand, inhibits colorectal cancer cells proliferation through β-catenin/TCF pathway inactivation.
    Zurlo D; Assante G; Moricca S; Colantuoni V; Lupo A
    Biochim Biophys Acta; 2014 Jul; 1840(7):2361-72. PubMed ID: 24735796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulating the balance between peroxisome proliferator-activated receptor gamma and beta-catenin signaling during adipogenesis. A glycogen synthase kinase 3beta phosphorylation-defective mutant of beta-catenin inhibits expression of a subset of adipogenic genes.
    Liu J; Farmer SR
    J Biol Chem; 2004 Oct; 279(43):45020-7. PubMed ID: 15308623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of peroxisome proliferator-activated receptor gamma promotes tumorigenesis through activation of the beta-catenin / T cell factor (TCF) pathway in the mouse intestine.
    Fujisawa T; Sugiyama M; Tomimoto A; Wada K; Endo H; Takahashi H; Yoneda K; Yoneda M; Inamori M; Saito S; Terauchi Y; Kadowaki T; Tsuchiya N; Nakagama H; Nakajima A
    J Pharmacol Sci; 2008 Dec; 108(4):535-44. PubMed ID: 19075513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor gamma (PPARgamma) suppresses colonic epithelial cell turnover and colon carcinogenesis through inhibition of the beta-catenin/T cell factor (TCF) pathway.
    Fujisawa T; Nakajima A; Fujisawa N; Takahashi H; Ikeda I; Tomimoto A; Yonemitsu K; Nakajima N; Kudo C; Wada K; Kubota N; Terauchi Y; Kadowaki T; Nakagama H; Blumberg RS
    J Pharmacol Sci; 2008 Apr; 106(4):627-38. PubMed ID: 18391483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor gamma activation can regulate beta-catenin levels via a proteasome-mediated and adenomatous polyposis coli-independent pathway.
    Sharma C; Pradeep A; Wong L; Rana A; Rana B
    J Biol Chem; 2004 Aug; 279(34):35583-94. PubMed ID: 15190077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A small-molecule inhibitor of Tcf/beta-catenin signaling down-regulates PPARgamma and PPARdelta activities.
    Handeli S; Simon JA
    Mol Cancer Ther; 2008 Mar; 7(3):521-9. PubMed ID: 18347139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of PPARgamma activity during adipogenesis.
    Farmer SR
    Int J Obes (Lond); 2005 Mar; 29 Suppl 1():S13-6. PubMed ID: 15711576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional interaction of DNA topoisomerase IIalpha with the beta-catenin and T-cell factor-4 complex.
    Huang L; Shitashige M; Satow R; Honda K; Ono M; Yun J; Tomida A; Tsuruo T; Hirohashi S; Yamada T
    Gastroenterology; 2007 Nov; 133(5):1569-78. PubMed ID: 17983804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex.
    Hämmerlein A; Weiske J; Huber O
    Cell Mol Life Sci; 2005 Mar; 62(5):606-18. PubMed ID: 15747065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know?
    Mulholland DJ; Dedhar S; Coetzee GA; Nelson CC
    Endocr Rev; 2005 Dec; 26(7):898-915. PubMed ID: 16126938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Wnt/beta-catenin signaling pathway targets PPARgamma activity in colon cancer cells.
    Jansson EA; Are A; Greicius G; Kuo IC; Kelly D; Arulampalam V; Pettersson S
    Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1460-5. PubMed ID: 15665104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visualization and exploration of Tcf/Lef function using a highly responsive Wnt/β-catenin signaling-reporter transgenic zebrafish.
    Shimizu N; Kawakami K; Ishitani T
    Dev Biol; 2012 Oct; 370(1):71-85. PubMed ID: 22842099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromatin-specific regulation of LEF-1-beta-catenin transcription activation and inhibition in vitro.
    Tutter AV; Fryer CJ; Jones KA
    Genes Dev; 2001 Dec; 15(24):3342-54. PubMed ID: 11751639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysine residues Lys-19 and Lys-49 of beta-catenin regulate its levels and function in T cell factor transcriptional activation and neoplastic transformation.
    Winer IS; Bommer GT; Gonik N; Fearon ER
    J Biol Chem; 2006 Sep; 281(36):26181-7. PubMed ID: 16849322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of SP5 as a downstream gene of the beta-catenin/Tcf pathway and its enhanced expression in human colon cancer.
    Takahashi M; Nakamura Y; Obama K; Furukawa Y
    Int J Oncol; 2005 Dec; 27(6):1483-7. PubMed ID: 16273202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LRP6 mediates Wnt/β-catenin signaling and regulates adipogenic differentiation in human mesenchymal stem cells.
    Peröbner I; Karow M; Jochum M; Neth P
    Int J Biochem Cell Biol; 2012 Nov; 44(11):1970-82. PubMed ID: 22871567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive expression of PPARγ inhibits proliferation and migration of gastric cancer cells and down-regulates Wnt/β-Catenin signaling pathway downstream target genes TERT and ENAH.
    Guo F; Ren X; Dong Y; Hu X; Xu D; Zhou H; Meng F; Tian W; Zhao Y
    Gene; 2016 Jun; 584(1):31-37. PubMed ID: 26956036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical and functional cooperation between AP-1 and beta-catenin for the regulation of TCF-dependent genes.
    Toualbi K; Güller MC; Mauriz JL; Labalette C; Buendia MA; Mauviel A; Bernuau D
    Oncogene; 2007 May; 26(24):3492-502. PubMed ID: 17146436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative evaluation of beta-catenin and plakoglobin signaling activity.
    Williams BO; Barish GD; Klymkowsky MW; Varmus HE
    Oncogene; 2000 Nov; 19(50):5720-8. PubMed ID: 11126358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.